A phase II study of S-1 in gemcitabine-refractory metastatic pancreatic cancer.
Morizane C, Okusaka T, Furuse J, Ishii H, Ueno H, Ikeda M, Nakachi K, Najima M, Ogura T, Suzuki E.
Morizane C, et al. Among authors: ishii h.
Cancer Chemother Pharmacol. 2009 Jan;63(2):313-9. doi: 10.1007/s00280-008-0741-7. Epub 2008 Apr 9.
Cancer Chemother Pharmacol. 2009.
PMID: 18398614
Clinical Trial.